Latest News in the pharma Industry
Research & Development
.jpg)
Hope on the horizon for hair loss sufferers
13 Mar 2018
First patient treated in Follicum’s Phase IIa study of FOL-005 for stimulation of hair growth.
Read more
Biogen to acquire first-in-class Phase IIb ready asset for cognitive impairment
12 Mar 2018
PF-04958242 is an AMPA receptor potentiator designed to facilitate neurotransmission.
Read more.png)
New Cosentyx data look promising for patients with scalp psoriasis
21 Feb 2018
Majority of patients with scalp psoriasis on Cosentyx (secukinumab) achieved clear skin at Weeks 12 and 24 and improved quality of life.
Read more.png)
Lonza to establish cell- and gene-therapy Centers of Excellence to accelerate growth
20 Feb 2018
The Centers of Excellence will allow custoners to access customer-centric solutions.
Read more
Expanded GXP compliance increases Concept's breadth of services
9 Feb 2018
Successful MHRA inspection at Dundee site confirms GLP accreditation for in vitro safety studies and bioanalysis.
Read more.jpg)
'Effective' hair loss treatment candidate advances to Phase IIa
7 Feb 2018
German Medicines Agency sees potential in FOL-005 - a modified version of the endogenous protein, osteopontin - the green light for further studies.
Read more
Metrion Biosciences awarded £200k funding to further develop in-house drug discovery pipeline
6 Feb 2018
Funding will support further development of recently acquired small molecule assets for treatment of autoimmune disease.
Read more
Lab automation systems for faster scientific breakthroughs
5 Feb 2018
PAA showcases its complete range of automation solutions, suitable for any type of laboratory or application, at SLAS2018.
Read more
Sanofi, DNDi seek EMA review for sleeping sickness treatment
1 Feb 2018
Fexinidazole would be first all-oral treatment under investigation for both first and second stages of sleeping sickness, a fatal disease, endemic in Africa.
Read more.jpg)
Collaboration expanded to explore synthetically feasible chemical space
25 Jan 2018
Enamine REAL database of synthetic compounds accessible via UCSF’s online ZINC platform.
Read more
Partnership in AI and machine learning for target discovery
23 Jan 2018
LifeArc and Milner Therapeutics Institute to develop, validate and integrate cutting-edge machine learning approaches into drug discovery processes.
Read more
Charles River acquisition enhances discovery expertise
18 Jan 2018
KWS increases Charles River's ability to support clients’ early-stage drug research in critical therapeutic areas.
Read more